NGM BIOPHARMACEUTICALS INC Total Liabilities
NGM BIOPHARMACEUTICALS INC had Total Liabilities of $20.23 million as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2024-03-11
- 2023-12-31: Liabilities $20.23M.
- 2023-09-30: Liabilities $22.34M.
- 2023-06-30: Liabilities $28.42M.
- 2023-03-31: Liabilities $37.90M.
| Period end | Liabilities |
|---|---|
| 2023-12-31 | $20.23M 10-K · filed 2024-03-11 |
| 2023-09-30 | $22.34M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $28.42M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $37.90M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $47.84M 10-K · filed 2024-03-11 |
| 2022-09-30 | $49.98M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $45.29M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $48.64M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $66.74M 10-K · filed 2023-02-28 |
| 2021-09-30 | $61.82M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $49.94M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $45.96M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $49.00M 10-K · filed 2022-03-01 |
| 2020-09-30 | $49.38M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $46.12M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $41.73M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $49.68M 10-K · filed 2021-03-15 |
| 2019-09-30 | $51.43M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $50.57M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $55.73M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $59.41M 10-K · filed 2020-03-17 |